2 doctors weighed in:
Cellcept (mycophenolate mofetil) for patients with antibody-negative myasthenia gravis; is it worth a trial?
2 doctors weighed in

Dr. John Goldman
Internal Medicine - Rheumatology
1 doctor agrees
In brief: Yes
It is not clear exactly how the autoantibodies work.
Antibody identification may not be 100 % and there may be other antibodies that have not been detected. Depending on what therapy has been tried CellCept (mycophenolate mofetil) may be appropriate. This is best discussed with your physician.

In brief: Yes
It is not clear exactly how the autoantibodies work.
Antibody identification may not be 100 % and there may be other antibodies that have not been detected. Depending on what therapy has been tried CellCept (mycophenolate mofetil) may be appropriate. This is best discussed with your physician.
Dr. John Goldman
Dr. John Goldman
Thank
Get help from a real doctor now
Dr. Bennett Machanic
Board Certified, Neurology
48 years in practice
55M people helped
Continue
108,000 doctors available
Read more answers from doctors